Skip to main content

Cyntellect Gets CE Mark for LEAP, Ships System to Undisclosed European Pharma

NEW YORK (GenomeWeb News) – Cyntellect said today that it has gained the European Union’s CE mark for its Laser-Enabled Analysis and Processing system.
 
The company said that it has also shipped a LEAP system to “a major pharmaceutical company customer in Europe,” marking the first commercial delivery of the system to the EU.
 
"CE marking of LEAP represents a major commercial milestone for Cyntellect and opens up an important market for our products," said Fred Koller, Cyntellect's president and CTO, in a statement.
 
LEAP is an automated instrument that combines optical imaging of cells, real-time image analysis, and high-speed laser manipulation of live cells in microplate formats.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.